These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 3580139)
1. Dose-dependent suppression of the high alcohol intake of chronically intoxicated rats by Ca-acetyl homotaurinate. Le Magnen J; Tran G; Durlach J; Martin C Alcohol; 1987; 4(2):97-102. PubMed ID: 3580139 [TBL] [Abstract][Full Text] [Related]
2. Lack of effects of Ca-acetyl homotaurinate on chronic and acute toxicities of ethanol in rats. Le Magnen J; Tran G; Durlach J Alcohol; 1987; 4(2):103-8. PubMed ID: 3580131 [TBL] [Abstract][Full Text] [Related]
3. Effects of acamprosate on ethanol-seeking and self-administration in the rat. Czachowski CL; Legg BH; Samson HH Alcohol Clin Exp Res; 2001 Mar; 25(3):344-50. PubMed ID: 11290844 [TBL] [Abstract][Full Text] [Related]
4. Acamprosate and alcohol: I. Effects on alcohol intake following alcohol deprivation in the rat. Spanagel R; Hölter SM; Allingham K; Landgraf R; Zieglgänsberger W Eur J Pharmacol; 1996 Jun; 305(1-3):39-44. PubMed ID: 8813529 [TBL] [Abstract][Full Text] [Related]
5. Acamprosate and alcohol: II. Effects on alcohol withdrawal in the rat. Spanagel R; Putzke J; Stefferl A; Schöbitz B; Zieglgänsberger W Eur J Pharmacol; 1996 Jun; 305(1-3):45-50. PubMed ID: 8813530 [TBL] [Abstract][Full Text] [Related]
6. Acamprosate and alcohol: III. Effects on alcohol discrimination in the rat. Spanagel R; Zieglgänsberger W; Hundt W Eur J Pharmacol; 1996 Jun; 305(1-3):51-6. PubMed ID: 8813531 [TBL] [Abstract][Full Text] [Related]
7. Acamprosate. A review of its pharmacology and clinical potential in the management of alcohol dependence after detoxification. Wilde MI; Wagstaff AJ Drugs; 1997 Jun; 53(6):1038-53. PubMed ID: 9179530 [TBL] [Abstract][Full Text] [Related]
8. Chronic acamprosate eliminates the alcohol deprivation effect while having limited effects on baseline responding for ethanol in rats. Heyser CJ; Schulteis G; Durbin P; Koob GF Neuropsychopharmacology; 1998 Feb; 18(2):125-33. PubMed ID: 9430136 [TBL] [Abstract][Full Text] [Related]
9. The glycine reuptake inhibitor Org24598 and acamprosate reduce ethanol intake in the rat; tolerance development to acamprosate but not to Org24598. Lidö HH; Marston H; Ericson M; Söderpalm B Addict Biol; 2012 Sep; 17(5):897-907. PubMed ID: 21955180 [TBL] [Abstract][Full Text] [Related]
10. Induction of high voluntary ethanol intake in dependent rats. Marfaing-Jallat P; Le Magnen J Pharmacol Biochem Behav; 1982 Oct; 17(4):609-12. PubMed ID: 6891060 [TBL] [Abstract][Full Text] [Related]
11. Effect of chronic acamprosate treatment on voluntary alcohol intake and beta-endorphin plasma levels in rats selectively bred for high alcohol preference. Zalewska-Kaszubska J; Górska D; Dyr W; Czarnecka E Neurosci Lett; 2008 Feb; 431(3):221-5. PubMed ID: 18162308 [TBL] [Abstract][Full Text] [Related]
12. Alcohol effects during acamprosate treatment: a dose-response study in humans. Brasser SM; McCaul ME; Houtsmuller EJ Alcohol Clin Exp Res; 2004 Jul; 28(7):1074-83. PubMed ID: 15252294 [TBL] [Abstract][Full Text] [Related]
13. Acute effects of acamprosate and MPEP on ethanol Drinking-in-the-Dark in male C57BL/6J mice. Gupta T; Syed YM; Revis AA; Miller SA; Martinez M; Cohn KA; Demeyer MR; Patel KY; Brzezinska WJ; Rhodes JS Alcohol Clin Exp Res; 2008 Nov; 32(11):1992-8. PubMed ID: 18782337 [TBL] [Abstract][Full Text] [Related]
14. Comparison of dehydroepiandrosterone (DHEA) and pregnanolone with existing pharmacotherapies for alcohol abuse on ethanol- and food-maintained responding in male rats. Hulin MW; Lawrence MN; Amato RJ; Weed PF; Winsauer PJ Alcohol; 2015 Mar; 49(2):127-38. PubMed ID: 25620274 [TBL] [Abstract][Full Text] [Related]
15. The acute anti-craving effect of acamprosate in alcohol-preferring rats is associated with modulation of the mesolimbic dopamine system. Cowen MS; Adams C; Kraehenbuehl T; Vengeliene V; Lawrence AJ Addict Biol; 2005 Sep; 10(3):233-42. PubMed ID: 16109584 [TBL] [Abstract][Full Text] [Related]
16. Anti-craving compounds for ethanol: new pharmacological tools to study addictive processes. Spanagel R; Zieglgänsberger W Trends Pharmacol Sci; 1997 Feb; 18(2):54-9. PubMed ID: 9090311 [TBL] [Abstract][Full Text] [Related]
17. A homotaurine derivative reduces the voluntary intake of ethanol by rats: are cerebral GABA receptors involved? Boismare F; Daoust M; Moore N; Saligaut C; Lhuintre JP; Chretien P; Durlach J Pharmacol Biochem Behav; 1984 Nov; 21(5):787-9. PubMed ID: 6096898 [TBL] [Abstract][Full Text] [Related]
18. Urinary ethyl glucuronide and ethyl sulfate testing for recent drinking in alcohol-dependent outpatients treated with acamprosate or placebo. Dahl H; Hammarberg A; Franck J; Helander A Alcohol Alcohol; 2011; 46(5):553-7. PubMed ID: 21616946 [TBL] [Abstract][Full Text] [Related]
19. Glycine receptors in the nucleus accumbens involved in the ethanol intake-reducing effect of acamprosate. Chau P; Höifödt-Lidö H; Löf E; Söderpalm B; Ericson M Alcohol Clin Exp Res; 2010 Jan; 34(1):39-45. PubMed ID: 19860809 [TBL] [Abstract][Full Text] [Related]
20. Acute and long term effects of buspirone treatments on voluntary ethanol intake in a rat model of alcoholism. Hedlund L; Wahlström G Alcohol Clin Exp Res; 1999 May; 23(5):822-7. PubMed ID: 10371401 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]